Bei Zhang
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 87
- Colorectal Cancer Treatments and Studies 32
- Cancer Immunotherapy and Biomarkers 27
- Cancer Treatment and Pharmacology 9
- Hepatology 15
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Co-authors
- Huijuan QiuWenzhuo HeChang JiangLiangping XiaGuifang GuoChenxi YinYuanyuan HuangYixin Zhou
- Journals
- Journal of Cancer (8 papers)Journal of Clinical Oncology (6 papers)Frontiers in Oncology (6 papers)Cancer Management and Research (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Bei Zhang
173 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 124
- Oncology 942
- Cancer Research 394
- Hepatology 208
- Pulmonary and Respiratory Medicine 464
- Otorhinolaryngology 53
Countries citing papers authored by Bei Zhang
This map shows the geographic impact of Bei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Zhang more than expected).
Fields of papers citing papers by Bei Zhang
This network shows the impact of papers produced by Bei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Zhang. The network helps show where Bei Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 4 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 3 | |
| 10 | 2022 | 7 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 8 | |
| 13 | 2018 | 13 | |
| 14 | 2017 | 8 | |
| 15 | 2017 | 20 | |
| 16 | 2017 | 22 | |
| 17 | 2017 | 9 | |
| 18 | 2014 | 5 | |
| 19 | 2014 | 9 | |
| 20 | 2009 | 26 |
About Bei Zhang
Bei Zhang is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Pathology and Forensic Medicine, having authored 191 papers that have together received 2.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (32 papers), Cancer Immunotherapy and Biomarkers (27 papers), Gastric Cancer Management and Outcomes (18 papers), Lung Cancer Treatments and Mutations (14 papers), Colorectal and Anal Carcinomas (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Genetic factors in colorectal cancer (10 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Oncology (942 citations), Cancer Research (394 citations), Hepatology (208 citations), Pulmonary and Respiratory Medicine (464 citations) and Otorhinolaryngology (53 citations). Bei Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Huijuan Qiu, Wenzhuo He, Chang Jiang, Liangping Xia, Guifang Guo, Chenxi Yin, Guifang Guo, Yuanyuan Huang, Yixin Zhou and Xiuyu Cai. Their work appears in journals such as Journal of Cancer, Journal of Clinical Oncology, Frontiers in Oncology, Cancer Management and Research and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.